P Van der Auwera

2.0k total citations
70 papers, 1.6k citations indexed

About

P Van der Auwera is a scholar working on Infectious Diseases, Pharmacology and Molecular Medicine. According to data from OpenAlex, P Van der Auwera has authored 70 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Infectious Diseases, 25 papers in Pharmacology and 21 papers in Molecular Medicine. Recurrent topics in P Van der Auwera's work include Antimicrobial Resistance in Staphylococcus (23 papers), Antibiotics Pharmacokinetics and Efficacy (23 papers) and Antibiotic Resistance in Bacteria (21 papers). P Van der Auwera is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (23 papers), Antibiotics Pharmacokinetics and Efficacy (23 papers) and Antibiotic Resistance in Bacteria (21 papers). P Van der Auwera collaborates with scholars based in Belgium, United States and Japan. P Van der Auwera's co-authors include Jean Klášterský, M. Husson, F. Meunier, F. Meunier–Carpentier, Roland Leclercq, Barbara E. Murray, Volkan Korten, Teruo Matsumoto, M. Aoun and C. Heymans and has published in prestigious journals such as Cancer, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

P Van der Auwera

70 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
P Van der Auwera Belgium 21 705 498 375 330 266 70 1.6k
Richard E. Bryant United States 24 713 1.0× 936 1.9× 310 0.8× 192 0.6× 225 0.8× 53 2.1k
Kyoichi Totsuka Japan 22 642 0.9× 552 1.1× 443 1.2× 308 0.9× 319 1.2× 73 1.6k
Douglas S. Kernodle United States 26 1.2k 1.7× 494 1.0× 181 0.5× 290 0.9× 353 1.3× 50 2.0k
Carl L. Pierson United States 22 346 0.5× 559 1.1× 154 0.4× 377 1.1× 217 0.8× 45 1.9k
K E Aldridge United States 22 366 0.5× 318 0.6× 367 1.0× 582 1.8× 333 1.3× 46 1.4k
M. P. Glauser Switzerland 16 315 0.4× 674 1.4× 212 0.6× 236 0.7× 112 0.4× 26 1.5k
Ómar Vesga Colombia 17 432 0.6× 272 0.5× 529 1.4× 176 0.5× 356 1.3× 34 1.3k
David Melnick United States 26 569 0.8× 707 1.4× 695 1.9× 142 0.4× 581 2.2× 55 2.0k
Jin‐Yong Jeong South Korea 24 447 0.6× 529 1.1× 148 0.4× 222 0.7× 281 1.1× 47 1.4k
Mao Hagihara Japan 28 712 1.0× 675 1.4× 430 1.1× 259 0.8× 336 1.3× 168 2.3k

Countries citing papers authored by P Van der Auwera

Since Specialization
Citations

This map shows the geographic impact of P Van der Auwera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Van der Auwera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Van der Auwera more than expected).

Fields of papers citing papers by P Van der Auwera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Van der Auwera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Van der Auwera. The network helps show where P Van der Auwera may publish in the future.

Co-authorship network of co-authors of P Van der Auwera

This figure shows the co-authorship network connecting the top 25 collaborators of P Van der Auwera. A scholar is included among the top collaborators of P Van der Auwera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Van der Auwera. P Van der Auwera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Reid, Donald, G. Nuki, Bernard Avouac, et al.. (1998). Recommendations for the registration of drugs used in the treatment of rheumatoid arthritis. Ghent University Academic Bibliography (Ghent University). 10 indexed citations
3.
Noriega, Lorena, P Van der Auwera, D. Daneau, F. Meunier, & Mabel Aoun. (1994). Salmonella infections in a cancer center. Supportive Care in Cancer. 2(2). 116–122. 24 indexed citations
4.
5.
Phan, Minh‐Duy, P Van der Auwera, Guy Andry, et al.. (1992). Antimicrobial prophylaxis for major head and neck surgery in cancer patients: sulbactam-ampicillin versus clindamycin-amikacin. Antimicrobial Agents and Chemotherapy. 36(9). 2014–2019. 19 indexed citations
6.
Auwera, P Van der, Gyula Prinz, & G. Petrikkos. (1991). Activity of intracellular antibiotics. Infection. 19(S4). S216–S223. 16 indexed citations
7.
Auwera, P Van der, et al.. (1990). Therapy of infections related to intraperitoneal catheters in patients with ovarian cancer. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 1 indexed citations
8.
Auwera, P Van der, et al.. (1990). Influence of teicoplanin and vancomydn on degranulation by polymorphonuclear leucocytes stimulated by various agonists: an in-vitro study. Journal of Antimicrobial Chemotherapy. 26(5). 683–688. 5 indexed citations
9.
Meunier, F., P Van der Auwera, M. Aoun, Martine Piccart, & Sculier Jp. (1990). Therapy of infections related to intraperitoneal catheters in patients with ovarian cancer.. PubMed. 72. 26–8. 3 indexed citations
10.
Klášterský, Jean & P Van der Auwera. (1989). In vitro activity of sulbactam in combination with various beta-lactam antibiotics. Diagnostic Microbiology and Infectious Disease. 12(4). 165–169. 13 indexed citations
11.
Matsumoto, Tetsuro, Joichi Kumazawa, & P Van der Auwera. (1989). Suppression of Leukocyte Function and Intracellular Content of ATP in Hyperosmotic Condition Comparable to the Renal Medulla. The Journal of Urology. 142(2 Part 1). 399–402. 23 indexed citations
12.
Auwera, P Van der & M. Husson. (1989). Influence of rifampicin and ansamycin on motility and adherence of human neutrophils studied in vitro. Journal of Antimicrobial Chemotherapy. 24(3). 347–353. 6 indexed citations
13.
Auwera, P Van der, G. Petrikkos, Teruo Matsumoto, & M. Husson. (1988). Influence of LY146032 on human polymorphonuclear leucocytes in vitro. Journal of Antimicrobial Chemotherapy. 21(1). 57–63. 27 indexed citations
14.
Legrand, J.C., et al.. (1986). Randomized study of minocycline + gentamicin compared with metronidazole + gentamicin for prophylaxis or treatment of mixed infections in abdominal surgery.. PubMed. 6(5). 361–8. 3 indexed citations
15.
Auwera, P Van der, et al.. (1985). Rapid diagnosis of Streptococcus pneumoniae infections by antigen detection in urine, serum and CSF. Annales de biologie clinique. 43(4). 401–405. 1 indexed citations
16.
Auwera, P Van der, Jean Klášterský, J.P. Thys, F. Meunier–Carpentier, & J.C. Legrand. (1985). Double-blind, placebo-controlled study of oxacillin combined with rifampin in the treatment of staphylococcal infections. Antimicrobial Agents and Chemotherapy. 28(4). 467–472. 45 indexed citations
17.
Auwera, P Van der & Jean Klášterský. (1984). Serum bactericidal activity of ampicillin and mezlocillin with and without sulbactam. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 10(5). 333–343. 8 indexed citations
18.
Frühling, J, et al.. (1984). 111Indium-oxine-labeled leukocytes in the diagnosis of localized infection in patients with neoplastic disease. Cancer. 54(5). 817–824. 26 indexed citations
19.
Auwera, P Van der, et al.. (1983). Comparison of kelfiprim (sulfamethopyrazine + trimethoprim) and cotrimoxazole (sulfamethoxazole + trimethoprim) in urinary tract infections. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 9(7). 561–566. 2 indexed citations
20.
Auwera, P Van der. (1983). In Vitro Study of the Combination of Rifampin with Oxacillin Against Staphylococcus aureus. Clinical Infectious Diseases. 5(Supplement_3). S509–S514. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard E. Bryant Breakdown of academic impact, for papers by Kyoichi Totsuka Breakdown of academic impact, for papers by Douglas S. Kernodle Breakdown of academic impact, for papers by Carl L. Pierson Breakdown of academic impact, for papers by K E Aldridge Breakdown of academic impact, for papers by M. P. Glauser Breakdown of academic impact, for papers by Ómar Vesga Breakdown of academic impact, for papers by David Melnick Breakdown of academic impact, for papers by Jin‐Yong Jeong Breakdown of academic impact, for papers by Mao Hagihara
Rankless by CCL
2026